Bristol-Myers Squibb Down Over 6%, On Track for Largest Percent Decrease Since March 2020 — Data Talk

Bristol-Myers Squibb Company (BMY) is currently at $45.58, down $3.28 or 6.71%

--Would be lowest close since Aug. 5, 2019, when it closed at $45.38

--On pace for largest percent decrease since March 18, 2020, when it fell 7.12%

--Currently down three consecutive days; down 7.24% over this period

--Worst three day stretch since the three days ending Oct. 30, 2023, when it fell 9.47%

--Down 15.95% month-to-date; on pace for worst month since Oct. 2018, when it fell 18.59%

--Down 11.16% year-to-date

--Down 43.82% from its all-time closing high of $81.13 on Dec. 2, 2022

--Down 32.58% from 52 weeks ago (April 27, 2023), when it closed at $67.61

--Down 34.01% from its 52-week closing high of $69.08 on May 11, 2023

--Would be a new 52-week closing low

--Traded as low as $45.11; lowest intraday level since Aug. 7, 2019, when it hit $45.08

--Down 7.67% at today's intraday low; largest intraday percent decrease since March 18, 2020, when it fell as much as 11.22%

--Seventh worst performer in the S&P 500 today

--10th most active stock in the S&P 500 today

All data as of 10:29:34 AM ET

Source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

April 25, 2024 10:47 ET (14:47 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.